Human Rotavirus Vaccine Market Share 2022: Global Trends, Key Players, Industry Analysis Report to 2028

The Human Rotavirus Vaccine Market size is expected to grow at an annual average of 11% during 2021-2027. Rotavirus is a virus that causes highly contagious diarrhea. By the age of five, most children have had the virus at least once before a vaccine was available. Rotavirus infection is unpleasant, but can often be treated at home with extra fluids to avoid dehydration. Severe dehydration may require you to get fluids given intravenously (through a vein) in a hospital. It is important to maintain proper hygiene, such as regular hand washing. On the other hand, vaccination is the most effective way to prevent rotavirus infection.

The following segmentation are covered in this report:

By Application

• Hospitals
• Clinics
• Academic & Research Lab

By Type

• Lanzhou Lamb
• Rotarix
• Rotavac
• Rotavin-M1
• Others

Company Profile

• GlaxoSmithKline plc
• Bharat Biotech
• Sanofi, Lanzhou Institute of Biologicals Products Co. Ltd
• QIMR Berghofer Medical Research Institute

Scope of the report

The research study analyses the Human Rotavirus Vaccine Market industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:

Recent developments

• Market overview and growth analysis
• Import and export overview
• Volume analysis
• Current market trends and future outlook
• Market opportunistic and attractive investment segment

Geographic coverage

• North america market size and/or volume
• Latin america market size and/or volume
• Europe market size and/or volume
• Asia-pacific market size and/or volume
• Rest of the world market size and/or volume

Key Questions Answered by Human Rotavirus Vaccine Market Report

• What was the Human Rotavirus Vaccine Market size in 2019 and 2020; what are the estimated growth trends and market forecast (2021-2027)
• What will be the CAGR of Market during the forecast period (2021-2027)?
• Which segments (product type/applications/end-user) were most attractive for investments in 2021? How these segments are expected to grow during the forecast period (2021-2027).
• Which manufacturer/vendor/players in the Human Rotavirus Vaccine Market was the market leader in 2020?
• Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.